Spots Global Cancer Trial Database for carcinomas
Every month we try and update this database with for carcinomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) | NCT01026415 | Carcinomas Disease, Hodgki... Lymphoma, Large... Lymphoma, Non-H... Neoplasms | brentuximab ved... rifampin midazolam ketoconazole brentuximab ved... | 18 Years - | Seagen Inc. | |
| Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease | NCT00535080 | Field Actinic K... Basal Cell Carc... Bowen's Disease | Metvix (methyl ... | 18 Years - | Galderma R&D | |
| AMG 386 Drug-Drug Interaction Study With Paclitaxel | NCT01992341 | Advanced Solid ... | AMG 386 Paclitaxel | 18 Years - | Amgen | |
| Symptom Assessment With Patient Surveys | NCT01135823 | Carcinomas Squamous Cell C... Adenocarcinoma | Patient survey | - 18 Years | Stanford University | |
| Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease | NCT00535080 | Field Actinic K... Basal Cell Carc... Bowen's Disease | Metvix (methyl ... | 18 Years - | Galderma R&D | |
| School Response to Families Who Have Children With Cancer | NCT01148082 | Carcinomas Squamous Cell C... Adenocarcinoma | Self administer... Interviews | 18 Years - | Stanford University | |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | NCT02574728 | Cancer | Sirolimus Celecoxib Etoposide Cyclophosphamid... | 12 Months - 30 Years | Emory University | |
| Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) | NCT01026415 | Carcinomas Disease, Hodgki... Lymphoma, Large... Lymphoma, Non-H... Neoplasms | brentuximab ved... rifampin midazolam ketoconazole brentuximab ved... | 18 Years - | Seagen Inc. | |
| Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla | NCT05347212 | Carcinomas Renal Medullary... | Nivolumab Relatlimab | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer | NCT00408603 | Epithelial Ovar... | Voreloxin Injec... | 18 Years - | Sunesis Pharmaceuticals | |
| Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix | NCT05063916 | Carcinomas Cervix Cancer Cervical Cancer | AK104 | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix | NCT05063916 | Carcinomas Cervix Cancer Cervical Cancer | AK104 | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment | NCT00935675 | Carcinomas | Escitalopram | 18 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| B-Receptor Signaling in Cardiomyopathy | NCT01135849 | Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer | - 40 Years | Stanford University | ||
| Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment | NCT00935675 | Carcinomas | Escitalopram | 18 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer | NCT00490334 | Neoplasms | 9 Years - 16 Years | Stanford University | ||
| B-Receptor Signaling in Cardiomyopathy | NCT01135849 | Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer | - 40 Years | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
